keyword
https://read.qxmd.com/read/36463815/physical-mental-multimorbidity-in-a-large-primary-health-care-population-in-stockholm-county-sweden
#21
REVIEW
Marina Taloyan, Hassan Alinaghizadeh, Björn Wettermark, Jan Hasselstrom Jan Hasselström, Bo Christer Bertilson
BACKGROUND: Multimorbidity of mental and physical disorders may be common. Our objectives were to estimate the prevalence of mental disorders and determine physical-mental multimorbidity relationships adjusted for sex and age within a primary care population in Region Stockholm, Sweden. METHODS: From 2.4 million Region Stockholm inhabitants, we included adult patients with ≥ 1 primary care consultation from 2013 through 2017. We clustered 40 physical diagnoses into 9 categories and grouped mental disorders into mild-moderate (i...
November 29, 2022: Asian Journal of Psychiatry
https://read.qxmd.com/read/36330413/nicotinic-acid-supplementation-contributes-to-the-amelioration-of-alzheimer-s-disease-in-mouse-models
#22
JOURNAL ARTICLE
Zhigang Wang, Zhenyou Zou, Qinghua Li
BACKGROUND: Alzheimer's disease (AD) is the most common cause of dementia. Effective therapy, early diagnosis, and intervention are still lacking. Non-drug therapy and lifestyle interventions have become important means to prevent the occurrence and progression of AD, with nutritional therapy being one such example. Nutritional therapy, as a non-pharmacological intervention for AD, has made significant progress and shown significant promise for the development of treatment regimens in recent years...
October 2022: Annals of Translational Medicine
https://read.qxmd.com/read/36269510/clinical-effectiveness-of-muscarinic-receptor-targeted-interventions-in-neuropsychiatric-disorders-a-systematic-review
#23
Shivani Vaidya, Alexandre A Guerin, Leigh C Walker, Andrew J Lawrence
BACKGROUND: For decades, treatment of mood disorders, psychoses, anxiety and dementia have been confounded by limited efficacy and high rates of treatment resistance. Preclinical and clinical evidence have highlighted disruption of cholinergic signalling in several neuropsychiatric conditions and examined intervention strategies including acetylcholinesterase inhibitors and nicotinic receptor-targeted intervention. However, the effectiveness of these approaches is often curtailed by on-target side effects...
November 2022: CNS Drugs
https://read.qxmd.com/read/36248033/cholinergic-regulation-of-object-recognition-memory
#24
REVIEW
Kana Okada, Kouichi Hashimoto, Kazuto Kobayashi
Object recognition memory refers to a basic memory mechanism to identify and recall various features of objects. This memory has been investigated by numerous studies in human, primates and rodents to elucidate the neuropsychological underpinnings in mammalian memory, as well as provide the diagnosis of dementia in some neurological diseases, such as Alzheimer's disease and Parkinson's disease. Since Alzheimer's disease at the early stage is reported to be accompanied with cholinergic cell loss and impairment in recognition memory, the central cholinergic system has been studied to investigate the neural mechanism underlying recognition memory...
2022: Frontiers in Behavioral Neuroscience
https://read.qxmd.com/read/36109439/beauty-of-the-beast-anticholinergic-tropane-alkaloids-in-therapeutics
#25
REVIEW
Kyu Hwan Shim, Min Ju Kang, Niti Sharma, Seong Soo A An
Tropane alkaloids (TAs) are among the most valued chemical compounds known since pre-historic times. Poisonous plants from Solanaceae family (Hyoscyamus niger, Datura, Atropa belladonna, Scopolia lurida, Mandragora officinarum, Duboisia) and Erythroxylaceae (Erythroxylum coca) are rich sources of tropane alkaloids. These compounds possess the anticholinergic properties as they could block the neurotransmitter acetylcholine action in the central and peripheral nervous system by binding at either muscarinic and/or nicotinic receptors...
September 16, 2022: Natural Products and Bioprospecting
https://read.qxmd.com/read/35956406/supplementation-with-nad-and-its-precursors-to-prevent-cognitive-decline-across-disease-contexts
#26
REVIEW
Jared M Campbell
The preservation of cognitive ability by increasing nicotinamide adenine dinucleotide (NAD+ ) levels through supplementation with NAD+ precursors has been identified as a promising treatment strategy for a number of conditions; principally, age-related cognitive decline (including Alzheimer's disease and vascular dementia), but also diabetes, stroke, and traumatic brain injury. Candidate factors have included NAD+ itself, its reduced form NADH, nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and niacin (or nicotinic acid)...
August 7, 2022: Nutrients
https://read.qxmd.com/read/35849187/complications-following-surgical-treatment-of-posterior-malleolar-fractures-an-analysis-of-300-cases
#27
JOURNAL ARTICLE
Annika Pauline Neumann, Livia Kroker, Franziska Beyer, Stefan Rammelt
AIMS: The treatment of ankle fractures and fracture-dislocations involving the posterior malleolus (PM) has undergone considerable changes over the past decade. The aim of our study was to identify risk factors related to the occurrence of complications in surgically treated ankle fractures with PM involvement. PATIENTS AND METHODS: We retrospectively analyzed 300 patients at a mean age of 57 years with 300 ankle fractures involving the PM treated surgically at our institution over a 12-year period...
June 2023: Archives of Orthopaedic and Trauma Surgery
https://read.qxmd.com/read/35649648/pet-imaging-of-cholinergic-neurotransmission-in-neurodegenerative-disorders
#28
REVIEW
Solveig Tiepolt, Philipp M Meyer, Marianne Patt, Winnie Deuther-Conrad, Swen Hesse, Henryk Barthel, Osama Sabri
As a neuromodulator, the neurotransmitter acetylcholine plays an important role in cognitive, mood, locomotor, sleep/wake, and olfactory functions. In the pathophysiology of most neurodegenerative diseases, such as Alzheimer disease (AD) or Lewy body disorder (LBD), cholinergic receptors, transporters, or enzymes are involved and relevant as imaging targets. The aim of this review is to summarize current knowledge on PET imaging of cholinergic neurotransmission in neurodegenerative diseases. For PET imaging of presynaptic vesicular acetylcholine transporters (VAChT), (-)-18 F-fluoroethoxybenzovesamicol (18 F-FEOBV) was the first PET ligand that could be successfully translated to clinical application...
June 2022: Journal of Nuclear Medicine
https://read.qxmd.com/read/35422212/role-of-caffeine-in-the-age-related-neurodegenerative-diseases-a-review
#29
REVIEW
Miroslav Pohanka
Caffeine, a simple purine alkaloid with the proper chemical name 1,3,7-trimethylpurine- 2,6-dione, is an abundant compound present in coffee, food and drugs. It interacts with various pathways of which antagonism of adenosine receptors is the most significant but the other physiological pathways can be influenced by caffeine as well. Interaction with glutamate and dopamine neurotransmission pathways, competition with other substrates on cytochrome P450, non-competitive inhibition of acetylcholinesterase, blocking of nicotinic acetylcholine receptor and competitive inhibition of cyclic nucleotide phosphodiesterase can be mentioned...
2022: Mini Reviews in Medicinal Chemistry
https://read.qxmd.com/read/35415206/a-novel-process-driving-alzheimer-s-disease-validated-in-a-mouse-model-therapeutic-potential
#30
JOURNAL ARTICLE
Susan A Greenfield, Gregory M Cole, Clive W Coen, Sally Frautschy, Ram P Singh, Marisa Mekkittikul, Sara Garcia-Ratés, Paul Morrill, Owen Hollings, Matt Passmore, Sibah Hasan, Nikisha Carty, Silvia Bison, Laura Piccoli, Renzo Carletti, Stephano Tacconi, Anna Chalidou, Matthew Pedercini, Tim Kroecher, Hubert Astner, Philip A Gerrard
Introduction: The neuronal mechanism driving Alzheimer's disease (AD) is incompletely understood. Methods: Immunohistochemistry, pharmacology, biochemistry, and behavioral testing are employed in two pathological contexts-AD and a transgenic mouse model-to investigate T14, a 14mer peptide, as a key signaling molecule in the neuropathology. Results: T14 increases in AD brains as the disease progresses and is conspicuous in 5XFAD mice, where its immunoreactivity corresponds to that seen in AD: neurons immunoreactive for T14 in proximity to T14-immunoreactive plaques...
2022: Alzheimer's & Dementia: Translational Research & Clinical Interventions
https://read.qxmd.com/read/35350170/new-onset-dementia-among-survivors-of-pneumonia-associated-with-severe-acute-respiratory-syndrome-coronavirus-2-infection
#31
JOURNAL ARTICLE
Adnan I Qureshi, William I Baskett, Wei Huang, S Hasan Naqvi, Chi-Ren Shyu
Background: Case series without control groups suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in cognitive deficits and dementia in the postinfectious period. Methods: Adult pneumonia patients with SARS-CoV-2 infection (index hospitalization) and age-, gender-, and race/ethnicity-matched contemporary control pneumonia patients without SARS-CoV-2 infection were identified from 110 healthcare facilities in United States...
April 2022: Open Forum Infectious Diseases
https://read.qxmd.com/read/35130968/cholinergic-receptor-binding-in-unimpaired-older-adults-mild-cognitive-impairment-and-alzheimer-s-disease-dementia
#32
JOURNAL ARTICLE
David L Sultzer, Aaron C Lim, Hailey L Gordon, Brandon C Yarns, Rebecca J Melrose
BACKGROUND: Cholinergic neurotransmitter system dysfunction contributes to cognitive impairment in Alzheimer's disease and other syndromes. However, the specific cholinergic mechanisms and brain structures involved, time course of alterations, and relationships with specific cognitive deficits are not well understood. METHODS: This study included 102 older adults: 42 cognitively unimpaired (CU), 28 with mild cognitive impairment (MCI), and 32 with Alzheimer's disease (AD) dementia...
February 7, 2022: Alzheimer's Research & Therapy
https://read.qxmd.com/read/35111883/prevalence-of-mental-health-conditions-among-6078-individuals-with-down-syndrome-in-the-united-states
#33
JOURNAL ARTICLE
Anne Rivelli, Veronica Fitzpatrick, Sagar Chaudhari, Laura Chicoine, Gengjie Jia, Andrey Rzhetsky, Brian Chicoine
Findings from a recent study of the largest documented cohort of individuals with Down syndrome (DS) in the United States described prevalence of common disease conditions and strongly suggested significant disparity in mental health conditions among these individuals as compared with age- and sex-matched individuals without DS. The retrospective, descriptive study reported herein is a follow-up to document prevalence of 58 mental health conditions across 28 years of data from 6078 individuals with DS and 30,326 age- and sex-matched controls...
2022: Journal of Patient-centered Research and Reviews
https://read.qxmd.com/read/35096291/transient-receptor-potential-v1-modulates-neuroinflammation-in-parkinson-s-disease-dementia-molecular-implications-for-electroacupuncture-and-rivastigmine
#34
JOURNAL ARTICLE
Sheng-Ta Tsai, Tzu-Hsuan Wei, Yu-Wan Yang, Ming-Kuei Lu, Shao San, Chon-Haw Tsai, Yi-Wen Lin
OBJECTIVES: Parkinson's disease (PD) is a common progressive neurodegeneration disease. Its incidence increases with age and affects about 1% of people over 60. Incidentally, transient receptor potential V1 (TRPV1) and its relation with neuroinflammation in mouse brain has been widely reported. MATERIALS AND METHODS: We used 6-hydroxydopamine (6-OHDA) to induce PDD in mice. We then used the Morris water maze and Bio-Plex to test learning and inflammatory mediators in mouse plasma...
October 2021: Iranian Journal of Basic Medical Sciences
https://read.qxmd.com/read/34757527/meta-analysis-on-nicotine-s-modulation-of-hiv-associated-dementia
#35
JOURNAL ARTICLE
Velu Krishnan, Michael Vigorito, Nikhil K Kota, Sulie L Chang
HIV-Associated Dementia (HAD) is a significant comorbidity that many HIV-patients face. Our study utilized QIAGEN Ingenuity Pathway Analysis (IPA) to identify and analyze molecular profiles and pathways underlying nicotine's impact on HAD pathology. The Qiagen Knowledge Base (QKB) defines HAD as "Dementia associated with acquired immunodeficiency syndrome (disorder)." Although much remains unknown about HAD pathology, the curated research findings from the QKB shows 5 upregulated molecules that are associated with HAD + : CCL2 (Chemokine (C-C motif) ligand 2), L-glutamic acid, GLS (Glutaminase), POLG (DNA polymerase subunit gamma), and POLB (DNA polymerase subunit beta)...
December 2022: Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology
https://read.qxmd.com/read/34718293/comorbidities-in-alcohol-use-disorders-in-tuzla-canton-area-bosnia-and-herzegovina
#36
JOURNAL ARTICLE
Miralem Mešanović, Izet Pajević, Mevludin Hasanović
INTRODUCTION: Previous research has shown the simultaneous presence of health diseases and alcohol use disorder (AUD). This research emphasizes the importance of individual diseases, the simultaneous presence and connection of different diseases, which creates the conditions for more adequate treatment of patients with AUD. Determine somatic, neurological and psychiatric diseases in patients with AUD in the Tuzla Canton (TK) in the period from 01.01.2011. to 31.12.2015. SUBJECTS AND METHODS: A retrospective study on the systematic cause of 1,863 patients with AUD recorded in the TK health system...
April 2021: Psychiatria Danubina
https://read.qxmd.com/read/34616271/cholinergic-receptor-modulation-as-a-target-for-preventing-dementia-in-parkinson-s-disease
#37
REVIEW
Alexandre Iarkov, Cristhian Mendoza, Valentina Echeverria
Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) in the midbrain resulting in progressive impairment in cognitive and motor abilities. The physiological and molecular mechanisms triggering dopaminergic neuronal loss are not entirely defined. PD occurrence is associated with various genetic and environmental factors causing inflammation and mitochondrial dysfunction in the brain, leading to oxidative stress, proteinopathy, and reduced viability of dopaminergic neurons...
2021: Frontiers in Neuroscience
https://read.qxmd.com/read/34580158/characterization-of-the-brain-functional-architecture-of-psychostimulant-withdrawal-using-single-cell-whole-brain-imaging
#38
JOURNAL ARTICLE
Adam Kimbrough, Marsida Kallupi, Lauren C Smith, Sierra Simpson, Andres Collazo, Olivier George
Numerous brain regions have been identified as contributing to withdrawal behaviors, but it is unclear the way in which these brain regions as a whole lead to withdrawal. The search for a final common brain pathway that is involved in withdrawal remains elusive. To address this question, we implanted osmotic minipumps containing either saline, nicotine (24 mg/kg/d), cocaine (60 mg/kg/d), or methamphetamine (4 mg/kg/d) for one week in male C57BL/6J mice. After one week, the minipumps were removed and brains collected 8 h (saline, nicotine, and cocaine) or 12 h (methamphetamine) after removal...
November 2021: ENeuro
https://read.qxmd.com/read/34439563/mechanistic-basis-and-clinical-evidence-for-the-applications-of-nicotinamide-niacinamide-to-control-skin-aging-and-pigmentation
#39
REVIEW
Yong Chool Boo
Vitamin B3 (nicotinic acid, niacin) deficiency causes the systemic disease pellagra, which leads to dermatitis, diarrhea, dementia, and possibly death depending on its severity and duration. Vitamin B3 is used in the synthesis of the NAD+ family of coenzymes, contributing to cellular energy metabolism and defense systems. Although nicotinamide (niacinamide) is primarily used as a nutritional supplement for vitamin B3, its pharmaceutical and cosmeceutical uses have been extensively explored. In this review, we discuss the biological activities and cosmeceutical properties of nicotinamide in consideration of its metabolic pathways...
August 21, 2021: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/34387707/potentiation-of-cognitive-enhancer-effects-of-alzheimer-s-disease-medication-memantine-by-alpha7-nicotinic-acetylcholine-receptor-agonist-pha-543613-in-the-morris-water-maze-task
#40
JOURNAL ARTICLE
Nóra Bruszt, Zsolt Kristóf Bali, Sai Ambika Tadepalli, Lili Veronika Nagy, István Hernádi
RATIONALE: There are controversial pieces of evidence whether combination therapies using memantine and cholinesterase inhibitors are beneficial over their monotreatments. However, results of preclinical studies are promising when memantine is combined with agonists and allosteric modulators of the alpha7 nicotinic acetylcholine receptor (nAChR). OBJECTIVES: Here, we tested the hypothesis that cognitive enhancer effects of memantine can be potentiated through modulating alpha7 nAChRs in a scopolamine-induced amnesia model...
November 2021: Psychopharmacology
keyword
keyword
165699
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.